Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 19/20 | 0.57 |
| ▸ | PPARA | Q07869 | 19/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.57 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5308177 | 1.00 | PPARG (0.57) | PPARGPPARACYP2C9KCNH2KDR | |
| SCHEMBL5308181 | 1.00 | PPARG (0.57) | PPARGPPARACYP2C9KCNH2KDR | |
| SCHEMBL5224052 | 0.93 | PPARG (0.59) | PPARGPPARACYP2C9KCNH2KDR | |
| SCHEMBL5224038 | 0.93 | PPARG (0.59) | PPARGPPARACYP2C9KCNH2KDR | |
| SCHEMBL5227227 | 0.90 | PPARG (0.61) | PPARGPPARACYP2C9KCNH2KDR | |
| SCHEMBL5224923 | 0.90 | PPARG (0.61) | PPARGPPARACYP2C9KCNH2KDR | |
| SCHEMBL5224911 | 0.88 | PPARG (0.56) | PPARGPPARACYP2C9KCNH2KDR | |
| SCHEMBL5223176 | 0.85 | PPARG (0.57) | PPARGPPARACYP2C9KCNH2KDR | |
| SCHEMBL5225044 | 0.84 | PPARG (0.60) | PPARGPPARACYP2C9KCNH2KDR | |
| SCHEMBL5226992 | 0.84 | PPARG (0.60) | PPARGPPARACYP2C9KCNH2KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1778654-A1 | SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME | Crystalgenomics, Inc. (KR) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006006832-A1 | SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME | CRYSTALGENOMICS, INC. (KR) | 2006-01-19 | — | — | WO | disclosed |